SBC Medical Group Holdings Incorporated
NASDAQ:SBCConsulting Services
+$0.04 today
- Market cap
- $644.85M
- Beta
- 0.59
- P/E (TTM)
- 7.6
- EPS (TTM)
- $0.40
Volume 0.56M
Average 0.12M
SBC Pre-Tax Margin
Income before tax as a percentage of revenue.
SBC Medical Group Holdings IncorporatedNASDAQ: SBC
Pre-Tax Margin · Q1 FY2026 · quarter ended Mar 2026
Pre-tax margin narrows to 43.8%
Pre-tax margin was 43.8% in Q1 FY2026, down 22.7 pp from a year earlier. On a trailing-twelve-month basis it was 41.0%, up 1.8 pp year over year. Over 3 fiscal years it widened by 33.7 pp.
Context
- Pre-tax margin widened in 2 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
Sources:Income StatementText generated from reported figures; not investment advice.
Pre-Tax Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 47.3%
- Year-over-year change
- +11.5pp
| Period | Period end | Pre-Tax Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 47.3% | +11.5pp |
| FY2024 | 2024-12-31 | 35.8% | -2.3pp |
| FY2023 | 2023-12-31 | 38.0% | +24.4pp |
| FY2022 | 2022-12-31 | 13.6% | — |
Pre-Tax Margin vs competitors
How SBC compares with its peers on the latest reported figures
- SBC's LTM Mar 2026 pre-tax margin of 41.0% is the highest of the 3 companies compared; the peer median is 12.5%.
- Its year-over-year change of +1.8 pp is the 2nd highest of 3, against a peer median of +2.2 pp.
- Over three fiscal years its change of +33.7 pp compares with a peer median of +1.8 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
SBCSBC Medical Group Holdings Incorporated | LTM Mar 2026 | 41.0% | +1.8 pp | +33.7 pp |
RYOJrYojbaba Co., Ltd. Common Shares | FY2024 | 16.8% | +4.1 pp | — |
| LTM Mar 2026 | 8.3% | +0.2 pp | +1.8 pp | |
| Peer median (excluding SBC) | 12.5% | +2.2 pp | +1.8 pp | |
Competitors are the stored peer set for SBC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Revenue | 174.16M | 193.54M | 205.42M | 173.61M |
| Cost of Revenue | 59.33M | 56.24M | 49.37M | 46.32M |
| Gross Profit | 114.83M | 137.3M | 156.05M | 127.28M |
| Gross Margin | 65.9% | 70.9% | 76.0% | 73.3% |
| Research & Development | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 93.48M | 66.23M | 70.09M | 59.8M |
| Operating Expenses | 94.72M | 66.64M | 85.75M | 59.8M |
| Depreciation & Amortization | 5.93M | 12.25M | 3.8M | 2.68M |
| EBITDA | 29.64M | 85.87M | 77.28M | 84.91M |
| EBITDA Margin | 17.0% | 44.4% | 37.6% | 48.9% |
| Operating Income | 20.12M | 70.66M | 70.3M | 67.49M |
| Operating Margin | 11.6% | 36.5% | 34.2% | 38.9% |
| Interest Income | 472.38K | 86.75K | 19.94K | 198.32K |
| Interest Expense | 31.44K | 45.29K | 28.3K | 160.58K |
| Other Income / Expenses | 3.56M | 2.92M | 3.15M | 14.58M |
| Income Before Tax | 23.68M | 73.58M | 73.46M | 82.07M |
| Pre-Tax Margin | 13.6% | 38.0% | 35.8% | 47.3% |
| Income Tax Expense | 18.12M | 35.02M | 26.77M | 31.02M |
| Net Income | 6.32M | 39.37M | 46.61M | 50.99M |
| Net Margin | 3.6% | 20.3% | 22.7% | 29.4% |
| EPS (Basic) | 0.06 | 0.42 | 0.48 | 0.50 |
| EPS (Diluted) | 0.06 | 0.42 | 0.48 | 0.50 |
| Weighted Avg Shares | 15.07M | 94.19M | 96.56M | 103M |
| Weighted Avg Shares (Diluted) | 15.07M | 94.19M | 96.56M | 103M |
SBC Medical Group Holdings Incorporated
NASDAQ:SBC
Intrinsic Alpha fair value
Locked
Current Price
$6.27
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.